Onyx Biotec (ONYX)
STALWARTScore breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹34 |
| Market Cap | ₹61.29 Cr |
| P/E Ratio | 57.28 |
| ROCE | 12.16% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -130.1% |
| Debt/Equity | — |
| Sales Growth | 14.73% |
| Promoter Holding | 65.1% |
| 52-Week Range | ₹26.5 — ₹45 |
| Sector | Pharmaceuticals & Biotechnology |
Onyx Biotec trades with a P/E ratio of 57.28, ROCE of 12.16%, profit growth of -130.1%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer